Data from Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers
Authors:
- Douglas A. RubinsonDRDouglas A. Rubinson
- Noritaka TanakaNTNoritaka Tanaka
- Ferran Fece de la CruzFCFerran Fece de la Cruz
- Kevin S. KapnerKKKevin S. Kapner
- Michael H. RosenthalMRMichael H. Rosenthal
- Bryanna L. NordenBNBryanna L. Norden
- Haley BarnesHBHaley Barnes
- Sara EhnstromSESara Ehnstrom
- Alvin A. Morales-GironAMAlvin A. Morales-Giron
- Lauren K. BraisLBLauren K. Brais
- Christopher T. LemkeCLChristopher T. Lemke
- Andrew J. AguirreAAAndrew J. Aguirre
Open Access
- 1 May 2024
- other
- Published by American Association for Cancer Research (AACR)